Suppr超能文献

减肥手术对心血管疾病的影响:近期进展简要更新

Effects of Bariatric Surgery on Cardiovascular Disease: A Concise Update of Recent Advances.

作者信息

Kuno Toshiki, Tanimoto Eriko, Morita Sae, Shimada Yuichi J

机构信息

Department of Medicine, Mount Sinai Beth Israel Medical Center, New York, NY, United States.

Tokyo Medical and Dental University, Tokyo, Japan.

出版信息

Front Cardiovasc Med. 2019 Jul 10;6:94. doi: 10.3389/fcvm.2019.00094. eCollection 2019.

Abstract

Patients with obesity often have multiple cardiovascular comorbidities as obesity is an established risk factor for various cardiovascular diseases (CVDs)-e. g., heart failure (HF), coronary artery disease (CAD), hypertension, dysrhythmia, and venous thromboembolism. In the United States, obesity is the nationwide public health issue of the day with the prevalence exceeding 30%. It has become a substantial health and financial burden to the society and national healthcare system; the direct cost accounted for 150 billion US dollars in 2014. Lifestyle interventions have been shown to be successful in the short term, however their long-term results are still equivocal likely due to modest weight reduction and high recurrence rates. For instance, the mean weight reduction in a randomized controlled trial of patients with type 2 diabetes mellitus (DM) and either overweight or obesity was 6.0% in the intensive lifestyle modification arm and 3.5% in the control arm. On the contrary, bariatric surgery is known to be the most effective in achieving substantial and long-term weight loss and can prevent the development of CVD risk factors such as DM, hypertension, and dyslipidemia. Bariatric surgery induces prompt weight loss within a few months which lasts for at least 12-18 months, with mean weight loss of 35% (70% loss of excess weight), lowering the risk of all-cause mortality, myocardial infarction, and stroke. Furthermore, recent studies demonstrated that bariatric surgery contributed to the reduction of acute care use for HF, CAD, and hypertension. On the other hand, it was reported that bariatric surgery may worsen the control of certain types of CVD (e.g., dysrhythmia), especially in the early postoperative period. Additionally, the notion that being overweight or obese could contribute to higher survival rate in certain populations (e.g., patients with HF)-also known as "obesity paradox"-has been repetitively documented in the past, while most recent investigations suggested that the observed paradox may be attributable to confounding factors including pre-existing comorbidities. Considering the aforementioned advances in the field, this paper reviews a series of recent studies with regard to the short-term and long-term effects of bariatric surgery on various types of CVDs.

摘要

肥胖患者通常伴有多种心血管合并症,因为肥胖是各种心血管疾病(CVD)的既定危险因素,例如心力衰竭(HF)、冠状动脉疾病(CAD)、高血压、心律失常和静脉血栓栓塞。在美国,肥胖是当前全国性的公共卫生问题,患病率超过30%。它已成为社会和国家医疗保健系统的重大健康和经济负担;2014年直接成本达1500亿美元。生活方式干预在短期内已被证明是成功的,然而,由于体重减轻幅度不大且复发率高,其长期效果仍不明确。例如,在一项针对2型糖尿病(DM)且超重或肥胖患者的随机对照试验中,强化生活方式改变组的平均体重减轻了6.0%,而对照组为3.5%。相反,减重手术是实现显著长期体重减轻最有效的方法,并且可以预防CVD危险因素的发展,如DM、高血压和血脂异常。减重手术在几个月内可迅速减重,且至少持续12至18个月,平均体重减轻约35%(超重部分减轻约70%),降低了全因死亡率、心肌梗死和中风的风险。此外,最近的研究表明,减重手术有助于减少HF、CAD和高血压的急性护理使用。另一方面,有报道称减重手术可能会使某些类型的CVD(如心律失常)的控制恶化,尤其是在术后早期。此外,过去曾多次记录过超重或肥胖可能有助于某些人群(如HF患者)提高生存率这一观点,即所谓的“肥胖悖论”,而最近的调查表明,观察到的这种悖论可能归因于包括预先存在的合并症在内的混杂因素。考虑到该领域的上述进展,本文综述了一系列关于减重手术对各种类型CVD的短期和长期影响的最新研究。

相似文献

3
Bariatric metabolic surgery.减重代谢手术
Rozhl Chir. 2014 Aug;93(8):404-15.
4

引用本文的文献

本文引用的文献

3
The Impact of Obesity on the Cardiovascular System.肥胖对心血管系统的影响。
J Diabetes Res. 2018 Nov 4;2018:3407306. doi: 10.1155/2018/3407306. eCollection 2018.
7
Reducing the risk of heart failure exacerbation by bariatric surgery in obese patients.通过减肥手术降低肥胖患者心力衰竭加重的风险。
Expert Rev Endocrinol Metab. 2016 Sep;11(5):369-371. doi: 10.1080/17446651.2016.1221339. Epub 2016 Aug 17.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验